Us Drug-Coated Balloon for Coronary Artery Disease Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Drug-Coated Balloon for Coronary Artery Disease Market was valued at USD 1.2 Billion in 2022 and is projected to reach USD 2.5 Billion by 2030, growing at a CAGR of 10.1% from 2024 to 2030.
The US Drug-Coated Balloon (DCB) market for coronary artery disease (CAD) is rapidly evolving, offering significant advancements in the treatment of cardiovascular conditions. DCBs are specialized medical devices used in angioplasty procedures to treat narrowed or blocked coronary arteries, providing localized drug delivery that aids in preventing restenosis (re-narrowing of arteries). The balloon is coated with an antiproliferative drug, which is released during inflation to prevent excessive tissue growth. This innovation is transforming how cardiologists approach CAD treatment, improving outcomes and patient quality of life.
The US market for drug-coated balloons in coronary artery disease is expanding due to several factors. The increasing prevalence of CAD, advancements in medical technology, and a growing preference for minimally invasive procedures are driving demand. According to recent data, CAD remains one of the leading causes of death in the United States, creating a strong need for effective therapeutic solutions. Additionally, the aging population is a significant factor contributing to the rise in coronary artery diseases, further bolstering the market for DCBs.
With drug-coated balloons, patients experience fewer complications, shorter recovery times, and reduced hospital stays compared to traditional stent-based interventions. This is especially beneficial for individuals with smaller coronary arteries or those at high risk of restenosis, who may not be ideal candidates for stenting. The drug coating on the balloon, typically paclitaxel or sirolimus, has been proven to significantly reduce the occurrence of restenosis, making it a preferred choice in specific cases.
The US DCB market also benefits from continuous advancements in balloon design and drug formulation. Manufacturers are focusing on improving the efficiency of drug delivery, enhancing the balloons' ease of use, and ensuring better long-term outcomes for patients. As the technology improves, the cost-effectiveness and accessibility of DCBs are also expected to increase, expanding their reach across various healthcare facilities.
In line with these developments, the market's growth is being fueled by increased research and clinical trials assessing the effectiveness and safety of drug-coated balloons in treating complex coronary lesions. As the understanding of DCBs' potential expands, new applications may emerge, further enhancing their role in the management of coronary artery disease.
The increasing interest in drug-coated balloon technology is mirrored by its parallels in other medical fields, such as the "100 Gigabit Fiber Optic Transceiver Market," which similarly reflects technological advancement and the continuous push toward more efficient and effective medical solutions. These trends highlight the constant innovation across industries, as both sectors aim to improve patient care through better technology.
Get an In-Depth Research Analysis of the Global Drug-Coated Balloon for Coronary Artery Disease Market Size And Forecast [2025-2032]
B. Braun
Yinyi
Eurocor
Biotronic
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Drug-Coated Balloon for Coronary Artery Disease Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Drug-Coated Balloon for Coronary Artery Disease Market
Paclitaxel-Coated Balloons
Sirolimus-Coated Balloons
Other Drug-Coated Balloons
Coronary Artery Disease (CAD)
Peripheral Artery Disease (PAD)
Hospitals
Cardiac Centers
Ambulatory Surgical Centers
Non-Resorbable Drug-Coated Balloons
Resorbable Drug-Coated Balloons
Direct Sales
Distributors
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Drug-Coated Balloon for Coronary Artery Disease Market Research Analysis
1. Introduction of the Global Drug-Coated Balloon for Coronary Artery Disease Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Drug-Coated Balloon for Coronary Artery Disease Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Drug-Coated Balloon for Coronary Artery Disease Market, By Type
6. Global Drug-Coated Balloon for Coronary Artery Disease Market, By Application
7. Global Drug-Coated Balloon for Coronary Artery Disease Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Drug-Coated Balloon for Coronary Artery Disease Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/